https://clinicaltrials.gov/ct2/show/NCT03229252?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=03%2F05%2F2019&lupd_d=14
Condition : Cystic Fibrosis
Interventions : Drug: Placebo Inhalation Solution; Drug: SPX-101
Sponsor : Spyryx Biosciences, Inc.
Recruiting
An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
NCT03229252
Tue, 25 Jul 2017 12:00:00 EDT
Last Update Posted: 03/19/19 09:26AM
